Matches in Wikidata for { <http://www.wikidata.org/entity/Q90836802> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q90836802 description "article scientifique publié en 2018" @default.
- Q90836802 description "artículu científicu espublizáu n'avientu de 2018" @default.
- Q90836802 description "im Dezember 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90836802 description "scientific article published on 29 December 2018" @default.
- Q90836802 description "wetenschappelijk artikel" @default.
- Q90836802 description "наукова стаття, опублікована в грудні 2018" @default.
- Q90836802 name "Effective co-encapsulation of doxorubicin and irinotecan for synergistic therapy using liposomes prepared with triethylammonium sucrose octasulfate as drug trapping agent" @default.
- Q90836802 name "Effective co-encapsulation of doxorubicin and irinotecan for synergistic therapy using liposomes prepared with triethylammonium sucrose octasulfate as drug trapping agent" @default.
- Q90836802 type Item @default.
- Q90836802 label "Effective co-encapsulation of doxorubicin and irinotecan for synergistic therapy using liposomes prepared with triethylammonium sucrose octasulfate as drug trapping agent" @default.
- Q90836802 label "Effective co-encapsulation of doxorubicin and irinotecan for synergistic therapy using liposomes prepared with triethylammonium sucrose octasulfate as drug trapping agent" @default.
- Q90836802 prefLabel "Effective co-encapsulation of doxorubicin and irinotecan for synergistic therapy using liposomes prepared with triethylammonium sucrose octasulfate as drug trapping agent" @default.
- Q90836802 prefLabel "Effective co-encapsulation of doxorubicin and irinotecan for synergistic therapy using liposomes prepared with triethylammonium sucrose octasulfate as drug trapping agent" @default.
- Q90836802 P1433 Q90836802-EA97A6B2-3FD0-403A-81C2-BE0C3199CF81 @default.
- Q90836802 P1476 Q90836802-D26194E7-0C30-41A9-8F93-C89E9B87C87C @default.
- Q90836802 P2093 Q90836802-07AE0818-0888-479C-B840-3F68BAF639CA @default.
- Q90836802 P2093 Q90836802-4490D7BD-2772-4F6E-A2A0-CA1452321701 @default.
- Q90836802 P2093 Q90836802-6E58C697-1CAF-4D21-BE2C-ACCEC01365F2 @default.
- Q90836802 P2093 Q90836802-8398CA8C-70EE-4D21-B4E2-E67A4B2BD9D3 @default.
- Q90836802 P2093 Q90836802-A3798231-48E2-479B-B0BE-751CC6F11C1C @default.
- Q90836802 P2093 Q90836802-BBA8E48D-CE60-4BB3-93B8-B2AB6D8181DA @default.
- Q90836802 P2093 Q90836802-E308DCD1-EC3A-4F9F-A992-F737FA240037 @default.
- Q90836802 P304 Q90836802-6FAB0EEC-3031-46D8-A245-4ABAFA270717 @default.
- Q90836802 P31 Q90836802-2BC7574C-9125-4F10-9A85-711CCD06F47A @default.
- Q90836802 P356 Q90836802-B460EB2D-84C8-4085-847F-AD680441D127 @default.
- Q90836802 P478 Q90836802-7C3D3E4E-F223-4D3F-827D-C9CF257D8944 @default.
- Q90836802 P577 Q90836802-C56FD860-0BDB-43EC-AEE7-5D66D297EE4B @default.
- Q90836802 P698 Q90836802-60BC8753-F467-4FD7-9DB1-44E2A0BD2B37 @default.
- Q90836802 P921 Q90836802-4CECC694-25FC-469B-854D-0DE6C0A29BE5 @default.
- Q90836802 P921 Q90836802-5D45A1BF-5DC6-4E18-AE2D-B1A029B1254E @default.
- Q90836802 P356 J.IJPHARM.2018.12.072 @default.
- Q90836802 P698 30599233 @default.
- Q90836802 P1433 Q6051539 @default.
- Q90836802 P1476 "Effective co-encapsulation of doxorubicin and irinotecan for synergistic therapy using liposomes prepared with triethylammonium sucrose octasulfate as drug trapping agent" @default.
- Q90836802 P2093 "Dongxu Chi" @default.
- Q90836802 P2093 "Dun Wang" @default.
- Q90836802 P2093 "Jieru Liu" @default.
- Q90836802 P2093 "Liwen Zhao" @default.
- Q90836802 P2093 "Siyan Pan" @default.
- Q90836802 P2093 "Xue Wang" @default.
- Q90836802 P2093 "Yongjun Wang" @default.
- Q90836802 P304 "264-272" @default.
- Q90836802 P31 Q13442814 @default.
- Q90836802 P356 "10.1016/J.IJPHARM.2018.12.072" @default.
- Q90836802 P478 "557" @default.
- Q90836802 P577 "2018-12-29T00:00:00Z" @default.
- Q90836802 P698 "30599233" @default.
- Q90836802 P921 Q18936 @default.
- Q90836802 P921 Q412197 @default.